Clinical Correlates of HIV-Associated Neurocognitive Disorders in South Africa

[1]  R. Geskus,et al.  Gender differences in HIV progression to AIDS and death in industrialized countries: slower disease progression following HIV seroconversion in women. , 2008, American journal of epidemiology.

[2]  I. Sanne,et al.  The prevalence of hepatitis B co-infection in a South African urban government HIV clinic. , 2008, South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde.

[3]  S. Seedat,et al.  Utility of the HIV Dementia Scale (HDS) in identifying HIV dementia in a South African sample , 2008, Journal of the Neurological Sciences.

[4]  Oliver Laeyendecker,et al.  Effect of human immunodeficiency virus Type 1 (HIV-1) subtype on disease progression in persons from Rakai, Uganda, with incident HIV-1 infection. , 2008, The Journal of infectious diseases.

[5]  P. Seth,et al.  Clade‐specific differences in neurotoxicity of human immunodeficiency virus‐1 B and C Tat of human neurons: significance of dicysteine C30C31 motif , 2008, Annals of neurology.

[6]  I. Grant.  Neurocognitive disturbances in HIV , 2008, International review of psychiatry.

[7]  M. Swartz,et al.  Relation of lifetime trauma and depressive symptoms to mortality in HIV. , 2007, The American journal of psychiatry.

[8]  J. Becker,et al.  Updated research nosology for HIV-associated neurocognitive disorders , 2007, Neurology.

[9]  Frederick A. Schmitt,et al.  The HIV Dementia Scale: Predictive power in mild dementia and HAART , 2007, Journal of the Neurological Sciences.

[10]  D. Clifford,et al.  HIV-associated cognitive impairment in sub-Saharan Africa—the potential effect of clade diversity , 2007, Nature Clinical Practice Neurology.

[11]  N. Nakasujja,et al.  Frequency of and risk factors for HIV dementia in an HIV clinic in sub-Saharan Africa , 2007, Neurology.

[12]  C. Hall,et al.  Assessment of NeuroAIDS in the International Setting , 2007, Journal of Neuroimmune Pharmacology.

[13]  A. Nath,et al.  Neurologic complications: Challenges to the diagnosis and management of HIV dementia , 2006 .

[14]  S. Southwick,et al.  Developing an Agenda for Translational Studies of Resilience and Vulnerability Following Trauma Exposure , 2006, Annals of the New York Academy of Sciences.

[15]  H. Myers,et al.  Relationship between Alcohol Use/Abuse, HIV Infection and Neuropsychological Performance in African American Men , 2006, Journal of clinical and experimental neuropsychology.

[16]  P. Chua,et al.  Depression and neurocognitive performance in individuals with HIV/AIDS: 2‐year follow‐up , 2006, HIV medicine.

[17]  J. Leserman.  Sexual Abuse History: Prevalence, Health Effects, Mediators, and Psychological Treatment , 2005, Psychosomatic medicine.

[18]  K. Jellinger.  The Neurology of AIDS, 2nd edn , 2005 .

[19]  O. Selnes,et al.  The International HIV Dementia Scale: a new rapid screening test for HIV dementia , 2005, AIDS.

[20]  P. Narciso,et al.  Prevalence and risk factors for human immunodeficiency virus-associated neurocognitive impairment, 1996 to 2002: Results from an urban observational cohort , 2005, Journal of NeuroVirology.

[21]  M. Weiner,et al.  Heavy alcohol consumption in individuals with HIV infection: Effects on neuropsychological performance , 2005, Journal of the International Neuropsychological Society.

[22]  Brett T. Litz,et al.  Psychometric Properties of the Life Events Checklist , 2004, Assessment.

[23]  O. Selnes,et al.  Higher frequency of dementia in older HIV-1 individuals , 2004, Neurology.

[24]  Dan J Stein,et al.  Predictors of major depression in recently diagnosed patients with HIV/AIDS in South Africa. , 2004, AIDS patient care and STDs.

[25]  A. Mahadevan,et al.  Tat Protein of Human Immunodeficiency Virus Type 1 Subtype C Strains Is a Defective Chemokine , 2004, Journal of Virology.

[26]  A. d’Arminio Monforte,et al.  Cognitive and affective disorders associated to HIV infection in the HAART era: findings from the NeuroICONA study , 2002 .

[27]  Laura Fratiglioni,et al.  Risk factors for cognitive impairment in HIV-1-infected persons with different risk behaviors. , 2002, Archives of neurology.

[28]  A. Flisher,et al.  Exposure to violence and its relationship to psychopathology in adolescents , 2001, Injury prevention : journal of the International Society for Child and Adolescent Injury Prevention.

[29]  J. Becker,et al.  HIV-associated neurologic disease incidence changes: , 2001, Neurology.

[30]  J. Becker,et al.  Plasma viral load and CD4 lymphocytes predict HIV-associated dementia and sensory neuropathy , 1999, Neurology.

[31]  Susan Swindells,et al.  The Neurology of AIDS , 1998 .

[32]  K. Marder,et al.  Gender Differences in HIV-Related Neurological Progression in a Cohort of Injecting Drug Users Followed for 3.5 Years. , 1997, Journal of neuro-AIDS.

[33]  O. Selnes,et al.  HIV Dementia Scale: a rapid screening test. , 1995, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

[34]  O. Aasland,et al.  Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO Collaborative Project on Early Detection of Persons with Harmful Alcohol Consumption--II. , 1993, Addiction.

[35]  M. Mahari,et al.  Alcohol problems among patients attending five primary health care clinics in Harare city. , 1993, The Central African journal of medicine.

[36]  R. Mollica,et al.  The Harvard Trauma Questionnaire: Validating a Cross‐Cultural Instrument for Measuring Torture, Trauma, and Posttraumatic Stress Disorder in Indochinese Refugees , 1992, The Journal of nervous and mental disease.

[37]  R. Wilcox.  Pairwise comparisons of J independent regression lines over a finite interval, simultaneous pairwise comparison of their parameters, and the Johnson‐Neyman procedure , 1987 .

[38]  Steven L. Wise.  Book Reviews: Applied Statistics: Analysis of Variance and Regression (2nd ed.) Olive Jean Dunn and Virginia A. Clark New York: Wiley, 1987. xii + 445 pp , 1986 .

[39]  P. Sprent,et al.  Applied statistics: analysis of variance and regression , 1975 .

[40]  P. Satishchandra,et al.  Neuropsychological deficits in human immunodeficiency virus type 1 clade C-seropositive adults from South India , 2011, Journal of NeuroVirology.

[41]  M. Scott,et al.  Intimate partner violence and HIV risk in Kenya. , 2007 .

[42]  Dieter J. Meyerhoff,et al.  Effects of Alcohol and HIV Infection on the Central Nervous System , 2001, Alcohol research & health : the journal of the National Institute on Alcohol Abuse and Alcoholism.

[43]  I. Thior,et al.  Human immunodeficiency virus type 1 subtypes differ in disease progression. , 1999, The Journal of infectious diseases.

[44]  D. Sheehan,et al.  The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. , 1998, The Journal of clinical psychiatry.

[45]  F. Goebel,et al.  Epidemiology of AIDS dementia complex in Europe. AIDS in Europe Study Group. , 1996, Journal of acquired immune deficiency syndromes and human retrovirology : official publication of the International Retrovirology Association.

[46]  H. Kranzler,et al.  The Alcohol Use Disorders Identification Test (AUDIT): validation of a screening instrument for use in medical settings. , 1995, Journal of studies on alcohol.

[47]  S. West,et al.  Multiple Regression: Testing and Interpreting Interactions. , 1994 .

[48]  Bradley E. Huitema,et al.  The analysis of covariance and alternatives , 1980 .